Curcumin modulates SDF-1α/CXCR4-induced migration of human retinal endothelial cells (HRECs)

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 8, 2008, Pages 3305-3311

  Sameermahmood, Zaheer ^a   Balasubramanyam, Muthuswamy ^a   Saravanan, Thangavel ^a   Rema, Mohan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CALCIUM ION; CHEMOKINE RECEPTOR CXCR4; CURCUMIN; EGTAZIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; THYMIDINE; ANTINEOPLASTIC AGENT; CALCIUM; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; HETEROCYCLIC COMPOUND; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FLUOROMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETINA CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL SURVIVAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CALCIUM; CELL MIGRATION INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CXCL12; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HETEROCYCLIC COMPOUNDS; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 49049102116     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0456     Document Type: Article

References (39)

1. Beck L Jr, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J. 1997;11:365-373.
2. Penumathsa SV, Koneru S, Thirunavukkarasu M, Zhan L, Prasad K, Maulik N. Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury. J Pharmacol Exp Ther. 2007;320:951-959.
3. Cai J, Ahmad S, Jiang WG, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes. 2003;52:2959-2968.
4. Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol. 2003;140:637-646.
5. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51:1635-1639.
6. Harris VK, Coticchia CM, Kagan BL, Ahmad S, Wellstein A, Riegel AT. Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways. J Biol Chem. 2000;275:10802-10811.
7. Schultz GS, Grant MB. Neovascular growth factors. Eye. 1991;5:170-180.
8. Strasly M, Doronzo G, Capello P, et al. CCL16 activates an angiogenic program in vascular endothelial cells. Blood. 2004;103:40-49.
9. Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005;65:465-472.
10. Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1α/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 2005;280:35760-35766.
11. Panzer U, Uguccioni M. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. Eur J Immunol. 2004;34:3682-3689.
12. Schabath H, Runz S, Joumaa S, Altevogt P. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells. J Cell Sci. 2006;119:314-325.
13. Vanbervliet B, Bendriss-Vermare N, Massacrier C, et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1α)/CXCL12. J Exp Med. 2003;198:823-830.
14. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565-568.
15. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203(9):2201-2213.
16. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1α. Nat Med. 2004;10:858-864.
17. Hatch HM, Zheng D, Jorgensen ML, Petersen BE. SDF-1α/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells. 2002;4:339 -351.
18. Salvucci O, Basik M, Yao L, et al. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J Leukoc Biol. 2004;76:217-226.
19. Butler JM, Guthrie SM, Koc M, et al. SDF-1α is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest. 2005;115:86-93.
20. Arbiser JL, Klauber R, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4:376 -383.
21. Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci. 2006;47:2179-2184.
22. Goetze S, Xi XP, Kawano H, et al. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J Cardiovasc Pharmacol. 1999;33:798-806.
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
24. Balasubramanyam M, Kimura M, Aviv A, et al. Kinetics of calcium transport across the lymphocyte plasma membrane. Am J Physiol. 1993;265:C321-C327.
25. Fricker SP, Anastassov V, Cox J, et al. Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4. Biochem Pharmacol. 2006;72:588-596.
26. Canton A, Martinez-Caceres EM, Hernandez C, et al. CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy: a flow cytometric analysis. Arch Ophthalmol. 2004;122:743-749.
27. El-Ghrably IA, Dua HS, Orr GM, et al. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol. 2001;85:461-470.
28. Morales-Ruiz M, Fulton D, Sowa G, et al. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res. 2000;86:892-896.
29. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGFinduced endothelial cell migration. FEBS Lett. 2000;477:258-262.
30. Peng SB, Peek V, Zhai Y, et al. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1α/CXCR4-mediated migration of epithelioid carcinoma cells. Mol Cancer Res. 2005;3:227-236.
31. Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol. 1999;154:1125-1135.
32. Cherla RP, Ganju K. Stromal cell-derived factor 1α-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J Immunol. 2001;166:3067-3074.
33. Yoo JK, Kwon H, Khil LY, Zhang L, Jun HS, Yoon JW. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol. 2005;175:8280-8286.
34. 2+ store depletion in bovine vascular endothelial cells. J Physiol. 2000;523:549-559.
35. 2+-signaling enhances rat gastric microvascular endothelial cell migration. J Physiol Pharmacol. 2000;51:799-811.
36. 2+ release in rat skeletal muscle fibres. J Physiol. 2003;551:219-237.
37. + channels. J Biol Chem. 2007;282:1747-1756.
38. Hadri L, Pavoine C, Lipskaia L, Yacoubi S, Lompre AM. Transcription of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase type 3 gene, ATP2A3, is regulated by the calcineurin/NFAT pathway in endothelial cells. Biochem J. 2006;394:27-33.
39. 2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J Biol Chem. 2005;280:27130-27137.